Jurnal Kedokteran Meditek https://ejournal.ukrida.ac.id/index.php/Meditek <p><span style="font-weight: 400;">Jurnal Kedokteran Meditek (</span><em><span style="font-weight: 400;">J Kedokt Meditek</span></em><span style="font-weight: 400;">) (</span><a href="https://portal.issn.org/resource/ISSN/2406-8799"><span style="font-weight: 400;">e-ISSN: 2686-0201</span></a><span style="font-weight: 400;">, </span><a href="https://portal.issn.org/resource/ISSN/2087-7811"><span style="font-weight: 400;">p-ISSN: 2686-1437</span></a><span style="font-weight: 400;">) is a peer-reviewed journal that publishes open access articles. The journal is managed by Faculty of Medicines and Health Sciences, Krida Wacana Christian University. Start from 2025 Jurnal Kedokteran Meditek publishes six issues annually in January, March, May, July, September, and November.</span></p> <p><span style="font-weight: 400;">This journal's focus and scope encompass medical and health fields such as clinical medicine, community medicine, medical biology and biochemistry, molecular biology, bioinformatics, pharmacy and other biomedical sciences. This journal welcomes authors from the medical field or other health fields that are in line with the aim and scope of the journal.</span></p> <p><span style="font-weight: 400;">Jurnal Kedokteran Meditek holds a Third Grade (Sinta 3) of accreditation from National Journal Accreditation Board managed by the Ministry of Research, Technology and Higher Education, Republic of Indonesia Decree No 204/E/KPT/2022, since volume 28 Number 1 of 2022.</span></p> en-US meditek@ukrida.ac.id (Adit Widodo Santoso) adit.santoso@ukrida.ac.id (Adit W Santoso) Fri, 26 Sep 2025 12:32:54 +0000 OJS 3.3.0.8 http://blogs.law.harvard.edu/tech/rss 60 Profil Hemoglobin, Trombosit, dan Rasio Neutrofil Limfosit pada Pasien Kanker Kolorektal: Studi Deskriptif di RSUP Haji Adam Malik Medan https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3488 <p><em><strong>Introduction:</strong> Colorectal cancer is a global health problem with an increasing incidence. Monitoring cancer stage is crucial as it is closely related to therapeutic decisions, prognosis, and patient survival. Simple hematological parameters, such as hemoglobin, platelet count, and neutrophil-to-lymphocyte ratio, may aid in clinical evaluation. <strong>Objective</strong>: This study aimed to describe the profiles of hemoglobin, platelet count, and neutrophil-to-lymphocyte ratio in patients with colorectal cancer. <strong>Methods</strong>: The study employed a descriptive observational method with a cross-sectional approach. Secondary data were obtained from the medical records of 141 patients using the total sampling method. Data analysis was performed using descriptive statistics. <strong>Results</strong>: Anemia was found in 83% of patients, with a higher incidence at higher stages. Normal platelet counts were observed in 80% of patients, with decreasing proportions in higher stages. Elevated NLR was found in 78% of patients and was more frequent at higher stages of disease. <strong>Conclusion</strong>: These findings indicate the presence of anemia and a systemic inflammatory response, but not thrombocytosis. This research highlights the potential of these simple biomarkers in monitoring cancer stages and treatment strategies. </em></p> Ruth Vanessa Simatupang, Katharine, Bintang Yinke Magdalena Sinaga, Hafaz Zakky Abdillah Copyright (c) 2025 Ruth Vanessa Simatupang, Katharine, Bintang Yinke Magdalena Sinaga, Hafaz Zakky Abdillah https://creativecommons.org/licenses/by-sa/4.0 https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3488 Mon, 06 Oct 2025 00:00:00 +0000 Karakteristik Anak Penderita PJB dengan Pirau Kiri ke Kanan Disertai Pembesaran Ventrikel Kiri di RSPAL dr.Ramelan https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3535 <p><strong><em>Introduction: </em></strong><em>Congenital Heart Disease (CHD) is one of the most common congenital disabilities, with an incidence of 8-10 per 1000 live births in full-term infants and ten times higher in preterm infants. In Indonesia, the incidence of CHD is estimated at around 8 per 1000 live births. Understanding the anatomy and pathophysiology of the defect that occurs contributes to the accuracy of management planning<strong>. </strong><strong> Purpose: </strong>This study aims to identify the characteristics of pediatric patients with CHD featuring left-to-right shunt accompanied by left ventricular enlargement at RSPAL dr. Ramelan Surabaya from 2020 to 2023. <strong>Methods: </strong> The descriptive study uses secondary data (medical records) of pediatric CHD patients with left-to-right shunt and left ventricular enlargement, specifically focusing on ventricular septal defect (VSD) and patent ductus arteriosus (PDA) at the pediatric clinic of RSPAL dr. Ramelan. <strong>Results: </strong>Based on medical records from 45 samples, the majority of CHD patients were aged 1-12 months (23 children). CHD with VSD was more common in males (18 children), while PDA was more common in females (11 children). Most CHD patients showed no initial complaints (39 children) and did not have other types of congenital heart diseases, with 23 children having VSD and 10 having PDA. Additionally, most patients did not have comorbidities (39 children). Echocardiographic results indicated that most patients had an ejection fraction (EF) greater than 75% (27 children) and a fractional shortening (FS) greater than 45% (23 children). The main management involved echocardiographic evaluation and medication. <strong>Conclusion: </strong>The predominant age group for CHD cases at the pediatric clinic of RSPAL dr. Ramelan was 1-12 months, with echocardiographic results showing normal left ventricular function, with EF &gt;75% and FS &gt;45%. </em></p> Inggrid Fitria Maharani Subroto, Rizqi Rokhmadoni Pikir, Risma, Wienta Diarsvitri Copyright (c) 2025 Inggrid Fitria Maharani Subroto, Rizqi Rokhmadoni Pikir, Risma, Wienta Diarsvitri https://creativecommons.org/licenses/by-sa/4.0 https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3535 Fri, 26 Sep 2025 00:00:00 +0000 Profil HPV Genotyping dan Pap Smear LBC di MRCCC Siloam Hospitals Semanggi https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3811 <p><strong><em>Introduction:</em></strong><em> Cervical cancer is the second most common malignancy among Indonesian women after breast cancer, with 36,964 cases and 20,708 deaths in 2022. Cervical cancer screening studies using HPV genotyping and pap smear LBC have already been conducted in Indonesia using different methods. <strong>Purpose:</strong> The objectives of this study were to determine the HPV prevalence and genotype distribution, also the cytological results at MRCCC Siloam Hospitals Semanggi. <strong>Methods:</strong> A descriptive study with a cross-sectional design was conducted using 599 samples selected by consecutive non-random sampling from 2023–2024. HPV genotyping was performed using the DiagCor GenoFlow™ HPV array test, and pap smear analysis was conducted using PathTezt™ liquid-based cytology. <strong>Results:</strong> This study found 18.2% patients positive for HPV, comprising 58.7% with high-risk HPV only, 23% with low-risk HPV only, and 18.3% with mixed HPV infection</em> <em>Among all HPV-positive women, 53.2% had multiple HPV infections. The prevalence of high-risk HPV infection was 62.4%, with the most frequently detected genotypes were HPV-68, HPV-66, and HPV-52. The most frequent low-risk HPV infections were HPV-42, HPV-43, and HPV-44. Abnormal cytology results were found in 2.8% of patients, specifically ASC-US, LSIL, ASC-H, and AGC. <strong>Conclusion:</strong> The most prevalent HPV genotypes identified were HPV-68 (10.1%) and HPV-66 (9.6%). The study concludes that a positive HPV test is not always accompanied by abnormal cytology results. Therefore, HPV genotyping should be performed in conjunction with cytological examination for comprehensive screening. </em></p> Angeline Calista, Sony Sugiharto Copyright (c) 2025 Angeline Calista, Sony Sugiharto https://creativecommons.org/licenses/by-sa/4.0 https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3811 Fri, 26 Sep 2025 00:00:00 +0000 Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) Syndrome Associated with Liver Injury in Patient with Spondylarthritis: A Case Report https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3902 <p><strong>Introduction:</strong> Drug reaction with eosinophilia and systemic symptoms syndrome or DReSS is a rare and life-threatening severe hypersensitivity reaction characterized by multiorgan involvement, with the liver as the common visceral manifestation. Approximately 10% of patients showed no changes in their eosinophil count. Sulfasalazine and non-steroidal anti-inflammatory drugs are frequently associated with DReSS. The diagnosis of this syndrome remains challenging due to the variety of clinical presentations. <strong>Case Illustration:</strong> We reported a 48-year-old woman who presented with pruritic generalized morbilliform eruption accompanied by facial edema and fever. Five weeks prior, she was treated with sulfasalazine and diclofenac sodium for spondyloarthritis. Her laboratory results showed elevated liver, suggesting drug-induced liver injury. DReSS syndrome was diagnosed by applying the European RegiSCAR. A favorable outcome and recovery of liver function are significantly seen after withdrawal of the suspected drugs, supportive treatment, and administration of systemic corticosteroid. <strong>Discussion:</strong> Sulfasalazine was one of the drugs frequently reported to cause DReSS syndrome. Liver involvement ranges from reversible elevation of liver function tests to hepatic necrosis. Withdrawal of causative drugs and administration of methylprednisolone were recommended, particularly for DReSS with liver involvement. <strong>Conclusions:</strong> DReSS syndrome can manifest with typical skin lesions and multiorgan involvement despite the absence of eosinophilia. The leading cause of mortality related to acute liver injury ranges from mild transaminase to acute liver failure. Prompt cessation of the culprit drug, immunosuppressive therapy, and a multidisciplinary approach might prevent further complications and mortality<em>.</em></p> Eyleny Meisyah Fitri, Fatmah Azzuhra Lubis Copyright (c) 2025 Eyleny Meisyah Fitri, Fatmah Azzuhra Lubis https://creativecommons.org/licenses/by-sa/4.0 https://ejournal.ukrida.ac.id/index.php/Meditek/article/view/3902 Mon, 06 Oct 2025 00:00:00 +0000